✦ LIBER ✦

New Therapies Targeting the Genetic Mutations Responsible for Different Types of Melanoma

✍ Scribed by R. Botella-Estrada; O. Sanmartín Jiménez

Book ID: 119628221
Publisher: Elsevier Science
Year: 2010
Tongue: Spanish
Weight: 529 KB
Volume: 101
Category: Article
ISSN: 0001-7310
DOI: 10.1016/s1578-2190(10)70661-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic screening methods for the detect

Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1

✍ Katalin Balogh; Attila Patócs; Judit Majnik; Károly Rácz; László Hunyady 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 490 KB

O05 The role of the unfolded protein res

O05 The role of the unfolded protein response in neurodegeneration: a new target for therapy

✍ Mallucci, G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Identification of a new point mutation i

Identification of a new point mutation in the human xanthine dehydrogenase gene responsible for a case of classical type

✍ Norikazu Sakamoto; Tetsuya Yamamoto; Yuji Moriwaki; Tetsuya Teranishi; Masanori 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 53 KB

Genetic evidence that mutations in the g

Genetic evidence that mutations in the genes for non-collagenous domain of type IV collagen are not responsible for thin basement membrane disease

✍ Savige, J.A.; Wilson, D.; Delbridge, M. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Identification of a new point mutation i

Identification of a new point mutation in the human molybdenum cofactor sulferase gene that is responsible for xanthinuria type II

✍ Tetsuya Yamamoto; Yuji Moriwaki; Sumio Takahashi; Zenta Tsutsumi; Ka Tuneyoshi; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Functional analysis of three splicing mu

Functional analysis of three splicing mutations identified in the PMM2 gene: Toward a new therapy for congenital disorder of glycosylation type Ia

✍ Ana I. Vega; Celia Pérez-Cerdá; Lourdes R. Desviat; Gert Matthijs; Magdalena Uga 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

The congenital disorders of glycosylation (CDG) are a group of diseases caused by genetic defects affecting N-glycosylation. The most prevalent form of CDG-type Ia-is caused by defects in the PMM2 gene. This work reports the study of two new nucleotide changes (c.256-1G>C and c.640-9T>G) identified